Stocks and InvestingStocks and Investing
Fri, September 20, 2024
Thu, September 19, 2024
Wed, September 18, 2024
Tue, September 17, 2024

Akash Tewari Upgraded (BNTX) to Strong Buy and Increased Target to $150 on, Sep 17th, 2024


Published on 2024-10-28 14:19:14 - WOPRAI, Akash Tewari
  Print publication without navigation


Akash Tewari of Jefferies, Upgraded "BioNTech SE" (BNTX) to Strong Buy and Increased Target from $96 to $150 on, Sep 17th, 2024.

Akash has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 2 agree with Akash's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024


These are the ratings of the 3 analyists that currently disagree with Akash


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024
  • Emmanuel Papadakis of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $95 on, Wednesday, August 7th, 2024